Navigation Links
Dominant cholesterol-metabolism ideas challenged by new research
Date:8/15/2007

testine for excretion or destruction.

The expression of PS on the cell's surface might be accomplished in one of two ways. First, the enzyme that transports PS into the cell -- aminophospholipid translocase -- might be inhibited or blocked by ABCA1, causing a passive build-up of PS on the cell surface. Alternatively, ABCA1 might activate or might actually be the enzyme, scramblase, which causes PS and other phospholipids to redistribute until there are equal amounts inside and outside the cell membrane, making it possible to load the phospholipids and cholesterol onto apoA1.

During programmed cell death (apoptosis), PS is also expressed on the surface of apoptotic cells to signal macrophages to come and clean up the dead cells. Both the macrophages and apoptotic cells must express PS on their surfaces for this mechanism to work normally. Therefore, Chimini also proposed that ABCA1 might be part of the molecular machinery involved in apoptosis and macrophage activity.

The Penn State-Amherst team performed a complex series of experiments to determine whether the ABCA1 enzyme is either actively involved in the transmembrane transport of phospholipids or regulates another enzyme that transports the phospholipids. They also examined the role of ABCA1 enzyme in apoptosis and macrophage activity.

A key part of the study was using cells from sufferers of a rare genetic disorder, Tangier disease, who lack the ABCA1 gene. For comparison, the team also studied cells from experimental mice in which the gene for ABCA1 has been knocked out.

Exacting measurements of the movement of various phospholipids across the membrane of normal cells showed that the rate of phospholipid transport into the cell is not affected by the presence or absence of the ABCA1 gene and its corresponding enzyme. Similar experiments with Tangier cells or knock-out mouse cells produced the same results. "This showed us,"
'/>"/>

Contact: Barbara K. Kennedy
science@psu.edu
814-863-4682
Penn State
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Past experience of pheromones induces dominant courtship behavior in fruit flies
2. Dominant meerkats render rivals infertile
3. Agriculture and tropical conservation: rethinking old ideas
4. Researchers discover way to make cells in the eye sensitive to light
5. Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants
6. Columbia research lifts major hurdle to gene therapy for cancer
7. Researchers find how protein allows insects to detect and respond to pheromones
8. Researchers Uncover Key Step In Manufacture of Memory Protein
9. Research advances quest for HIV-1 vaccine
10. Research on Worms Yields Clues on Aging
11. U of M researcher examines newly emerging deadly disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... The loss of a gene through deletion of genetic m...icant abnormalities in learning and behavior, said... of Medicine ( www.bcm.edu ) in a report that appe... , "This research goes about 95 percent of the w...f individuals to this gene," said Dr. Arthur L. Be...
(Date:11/6/2009)...wire/ -- Auburn Hills, MI-based Law Enforcement In...ts locker system and patent-pending Biometric Acce...t of Health and Human Services, National Institute...er system will support the NIH,s entire police for... medical research agency. The project is expected...
(Date:11/4/2009)...ntists are reluctant to officially endorse green t...es to grow about its protective effects, including...ntion Research , a journal of the American Associa...ction in oral cancer. , Vassiliki Papadimitrako...nt of Thoracic/Head and Neck Medical Oncology at t...
Breaking Biology News(10 mins):Developmental delay could stem from nicotinic receptor deletion 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2New method may accelerate drug discovery for difficult diseases like Parkinsons 13002 1New method may accelerate drug discovery for difficult diseases like Parkinsons 13002 2New method may accelerate drug discovery for difficult diseases like Parkinsons 13002 3New method may accelerate drug discovery for difficult diseases like Parkinsons 13002 4Full Transcript of Pelosi Press Conference on Health Care Reform 51561 1Full Transcript of Pelosi Press Conference on Health Care Reform 51561 2Full Transcript of Pelosi Press Conference on Health Care Reform 51561 3Full Transcript of Pelosi Press Conference on Health Care Reform 51561 4Full Transcript of Pelosi Press Conference on Health Care Reform 51561 5Full Transcript of Pelosi Press Conference on Health Care Reform 51561 6Full Transcript of Pelosi Press Conference on Health Care Reform 51561 7Full Transcript of Pelosi Press Conference on Health Care Reform 51561 8Full Transcript of Pelosi Press Conference on Health Care Reform 51561 9Full Transcript of Pelosi Press Conference on Health Care Reform 51561 10Full Transcript of Pelosi Press Conference on Health Care Reform 51561 11Full Transcript of Pelosi Press Conference on Health Care Reform 51561 12Full Transcript of Pelosi Press Conference on Health Care Reform 51561 13Full Transcript of Pelosi Press Conference on Health Care Reform 51561 14Full Transcript of Pelosi Press Conference on Health Care Reform 51561 15Full Transcript of Pelosi Press Conference on Health Care Reform 51561 16Full Transcript of Pelosi Press Conference on Health Care Reform 51561 17Full Transcript of Pelosi Press Conference on Health Care Reform 51561 18TriWest Healthcare Alliance Awarded 5 Year 2416 Billion Healthcare Contract 51556 1TriWest Healthcare Alliance Awarded 5 Year 2416 Billion Healthcare Contract 51556 2
...are being slaughtered for their ivory at a pace un... took effect in 1989. But the public outcry that r...ity of Washington conservation biologist contends ...e giant mammals, plight. , The elephant death ra...ent a year based on recent studies, which is actua...
...d - Kiwifruit lovers can look forward to new, nove...ease this week of crucial genetic data which fruit...arieties with increased health properties and exci...ealand-based fruit science company HortResearch an...rch and Development Corporation Limited announced ...
...d a drug to achieve normal levels of blood sugar i...y high insulin levels. If this approach succeeds i...or children with congenital hyperinsulinism, a rar...hich insulin levels become dangerously high. , "T...or children with the most common type of congenita...
Other Biology News:Ivory poaching at critical levels: Elephants on path to extinction by 2020? 2Ivory poaching at critical levels: Elephants on path to extinction by 2020? 3Genetic data promises new future for kiwi fruit 2Genetic data promises new future for kiwi fruit 3Treatment corrects severe insulin imbalance in animal studies 2Treatment corrects severe insulin imbalance in animal studies 3
(Date:11/6/2009)...swire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ON...day announced updated results from a Phase II stud...omas metastatic to the lung in a poster presentati...ociety Meeting held in Miami Beach, Florida, from ...tled "A Phase II Study of Intravenous REOLYSIN (Wi...
(Date:11/5/2009).... 5 GenVec, Inc. (Nasdaq...r the third quarter ended September 30, 2009. GenV...share) for the three months ended September 30, 20...er share) in the comparable quarter of 2008. For t...net loss was $14.1 million ($0.15 per share), comp...
(Date:11/5/2009)..., Nov. 5 ThermoGenesis C...ative products for processing and storing adult st...rter of fiscal 2010. ,, For the quarter ended S...f $5.2 million, a 15 percent increase over revenue... The Company said the key contributors to the grow...
(Date:11/5/2009).... 5 Cepheid (Nasdaq: CP...peaking at the following investor conferences, and... Credit Suisse Healthcare Conferen...mber, 2009 at 10 a.m. Mountain Time, ...and, Tuesday, 1 December, 2009 at ...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Cepheid to Webcast Upcoming Financial Presentations 2
...ALTHAM, Mass., Aug. 18 Logical Therapeutics, Inc....nt of medicines that treat,diseases associated wit...the successful completion of its Phase 1b randomiz...cs study of LT-NS001, the Company,s proprietary,na...m December, 2007,through July, 2008 in normal adul...
...AN DIEGO, Aug. 18 LifeVantage Corporation,(OTC Bu...e only product,clinically proven to slow the progr...pany,s President & CEO, David Brown, is featured i...Press Show., The interview gives viewers an overv...mpany,s latest press release., To view the cli...
...HILADELPHIA, Aug. 17 /Xinhua-PRNewswire/ -- WuXi A...ech (NYSE: WX ) in the U.S., has announced,the ap... of Operations and,Joseph Hughes, Ph.D. as Vice Pr...acility., (Logo: http://www.newscom.com/cgi-bin/...ith the company for nine years in roles of,increas...
Other Biology Technology:Logical Therapeutics Inc. Announces Results of Phase 1b Clinical Study of its Naproxen Prodrug 2[video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.net's 3-Minute Press Show 2WuXi AppTec Appoints Garry Takle, Ph.D. as VP of Operations and Joseph Hughes, Ph.D. as VP of Testing Services for Philadelphia Facility 2
Smarter Fermentation System Controller for One Vessel from Major Science
...are specifically depleted of a single complement p..., the alternative and classical pathways are left ... detection and quantitation of hemolytically activ...used to assess complement activation in non-human ...
Dispensing Bins from Terra Universal, Inc.
Midgard Prec Current Source from Stoelting Co.
Biology Products: